Humacyte to Present Fourth Quarter and Full Year Financial R

DURHAM, N.C., March 21, 2023 -- Humacyte, Inc. , a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its... | March 21, 2023

Related Keywords

Joyce Allaire , Humacyte Inc , Lifesci Advisors , Nasdaq , Globenewswire Inc , Fourth Quarter , Call Details , Medicine Advanced Therapy , Investor Contact , Media Contact , Humacyte , Nc Stock Exchange , News , Information , Press Release , Arch , 023 , Biotechnology , Platform , Company , Developing , Universally , Implantable , Bioengineered , Human , Issue , It , Commercial , Hill , Elease Huma Us44486q1031 ,